RLYB Stock Analysis: Buy, Sell, or Hold?
RLYB - Rallybio Corporation Common Stock
$15.90
-0.02 (-0.13%)
▼
5d:
-0.06%
30d:
+11.89%
90d:
+68.97%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When RLYB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RLYB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RLYB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RLYB is currently trading at $15.90, which is considered slightly high relative to its 30-day fair value range of $14.28 to $16.02.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $14.21, while resistance sits at $17.57.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $8.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $14.21, while resistance sits at $17.57.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $8.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$14.28 -
$16.02
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 49.7% above Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$14.28 -
$16.02
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$14.21
Resistance Level
$17.57
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.42
Wall Street Target
$8.00
(-49.7%)
Share & Embed Analysis
Last updated: June 15, 2026 8:44 PM ET
Data refreshes hourly during market hours. Next update: 9:44 PM
Data refreshes hourly during market hours. Next update: 9:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLYB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan I Lieber
SELL
789 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$275 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 60 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 55 HOLD |
